Intertek acquires Melbourn Scientific Ltd

  Intertek acquires Melbourn Scientific Ltd

Business Wire

LONDON -- July 9, 2013

Intertek, the leading quality solutions provider to industries worldwide,
announces that it has acquired Melbourn Scientific Ltd (“Melbourn”), a leading
provider of analysis and development services for the pharmaceutical,
biopharmaceutical, biotechnology and healthcare industries.

Melbourn offers a range of expert services to support the global
pharmaceutical and healthcare industry including formulation and product
development, analytical method development and validation, stability studies
and QC release testing. It has profound expertise in all aspects of
characterisation of orally inhaled and intra-nasal products (OINDP) and
transdermal devices in addition to services for conventionally delivered
medicines. There is an increasing demand worldwide for more patient friendly
drug delivery methods for optimum therapeutic efficacy and efficiency and
enhanced patient outcomes.

Its formulation services respond to the need for re-formulation of existing
products to improve efficacy or extend patent life and to widen the market
potential for a given product. Moving from injection to oral inhalation, for
example, is a key strategy of many global Pharmaceutical majors to achieve
increased market share by improving bioavailability and drug use uptake within
a patient population (by improving delivery at the true target) whilst
reducing patient trauma.

Located in Royston, near Cambridge, in the UK, Melbourn’s business employs 80
staff. It’s 20,000 sqft facility is Good Manufacturing Practice (GMP)
compliant, regularly inspected by the UK Medicines and Health Regulatory
Authority (MHRA) and the FDA. The company’s reputation for providing
outstanding and responsive customer service along with its specialist skills
have fostered loyal customer relationships of which Melbourn is especially
proud and which complements Intertek’s existing technical capabilities and

Dr. Andrew Swift SVP Intertek Chemicals and Pharmaceuticals, says "Combining
Intertek’s GMP/ GLP pharmaceutical/ biopharmaceutical studies and our advanced
capabilities for measuring device/ drug interaction with Melbourn’s expertise
in OINDP drug characterisation provides a unique and compelling offering to
clients. Adding in our global reach and Regulatory Services, Intertek now
offers a comprehensive and global end to end expert service to support drug
development which is unmatched by current competitors.”

Intertek Chemicals & Pharmaceuticals

Intertek Chemicals & Pharmaceuticals helps organisations across a wide range
of industries to sharpen their competitive edge by providing advanced
measurement, expert consulting related technical support services, and
sustainability solutions. Our experts and laboratories provide critical
support to our clients in their global trade, not just with data, but with
essential knowledge to accelerate development of their next generation
products, to improve their manufacturing, products or production processes or
to enhance their efficiencies.

About Intertek

Intertek (ITRK.L) is the leading provider of quality and safety solutions
serving a wide range of industries around the world. From auditing and
inspection, to testing, quality assurance and certification, Intertek people
are dedicated to adding value to customers' products and processes, supporting
their success in the global marketplace. Intertek has the expertise, resources
and global reach to support its customers through its network of more than
1,000 laboratories and offices and over 35,000 people in more than 100
countries around the world. Visit


Dr Lorna Kettle, +44 161 721 1476
Marketing and Communications Manager, Intertek Chemicals and Pharmaceuticals
Press spacebar to pause and continue. Press esc to stop.